Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,720 ILa | +5.49% | -0.85% | -21.81% |
Jan. 10 | Joseph Herman acquired 3.33% stake in Panaxia Labs Israel Ltd for ILS 1 million. | CI |
Aug. 31 | Panaxia Labs Israel Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Sales 2021 | 83.6M 22.81M 8.36B | Sales 2022 | 39.42M 10.76M 3.94B | Capitalization | 28.3M 7.72M 2.83B |
---|---|---|---|---|---|
Net income 2021 | -21M -5.73M -2.1B | Net income 2022 | -43M -11.73M -4.3B | EV / Sales 2021 | 1.65 x |
Net Debt 2021 | 22.94 6.26 2.29K | Net Debt 2022 | 36.12 9.86 3.61K | EV / Sales 2022 | 0.72 x |
P/E ratio 2021 |
-6.21
x | P/E ratio 2022 |
-0.65
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 99% |
1 day | +5.49% | ||
1 week | -0.85% | ||
Current month | +31.39% | ||
1 month | +30.37% | ||
3 months | -17.81% | ||
6 months | +64.61% | ||
Current year | -21.81% |
Managers | Title | Age | Since |
---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 19-09-30 |
Assi Rotbart
CHM | Chairman | 48 | 19-09-30 |
Director of Finance/CFO | 66 | 22-12-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 53 | 21-12-28 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 16-07-20 |
Michal Sapir
BRD | Director/Board Member | 66 | 22-03-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 11,720 | +5.49% | 95 |
24-03-27 | 11,110 | -8.18% | 224 |
24-03-26 | 12,100 | -1.14% | 50 |
24-03-25 | 12,240 | +1.49% | 27 |
24-03-21 | 12,060 | +2.03% | 678 |
Delayed Quote TEL AVIV STOCK EXCHANGE, March 28, 2024 at 11:24 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-21.81% | 4.53M | |
+14.00% | 69.55B | |
+18.44% | 19.22B | |
+13.87% | 14.03B | |
+23.66% | 13.84B | |
0.00% | 12.95B | |
+1.98% | 10.25B | |
+17.40% | 10.12B | |
-31.78% | 5.96B | |
-5.07% | 5.92B |